ICCC ImmuCell Corporation Stock Quote

ICCC [NASD]

Index	-	P/E	-	EPS (ttm)	-0.19	Insider Own	0.10%	Shs Outstand	7.22M	Perf Week	-3.50%
Market Cap	71.22M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.52M	Perf Month	3.88%
Income	-1.30M	PEG	-	EPS next Q	0.05	Inst Own	9.50%	Short Float	0.23%	Perf Quarter	-11.63%
Sales	14.50M	P/S	4.91	EPS this Y	25.40%	Inst Trans	-0.14%	Short Ratio	0.55	Perf Half Y	71.40%
Book/sh	3.86	P/B	2.50	EPS next Y	-	ROA	-3.30%	Target Price	-	Perf Year	137.69%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-4.80%	52W Range	3.80 - 13.20	Perf YTD	62.19%
Dividend	-	P/FCF	-	EPS past 5Y	-18.70%	ROI	-1.40%	52W High	-26.89%	Beta	0.95
Dividend %	-	Quick Ratio	4.60	Sales past 5Y	8.40%	Gross Margin	42.80%	52W Low	153.94%	ATR	0.64
Employees	61	Current Ratio	5.60	Sales Q/Q	-16.30%	Oper. Margin	-13.70%	RSI (14)	47.71	Volatility	6.71% 6.83%
Optionable	No	Debt/Eq	0.33	EPS Q/Q	-260.60%	Profit Margin	-9.20%	Rel Volume	0.79	Prev Close	9.21
Shortable	Yes	LT Debt/Eq	0.30	Earnings	May 13 AMC	Payout	-	Avg Volume	22.85K	Price	9.65
Recom	2.00	SMA20	-2.48%	SMA50	-2.51%	SMA200	30.17%	Volume	17,942	Change	4.78%

May-14-21 07:15AM	ImmuCell Corp. to Host Earnings Call ACCESSWIRE
May-13-21 04:05PM	ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2021 GlobeNewswire
May-06-21 01:41PM	ImmuCell to Announce Unaudited Financial Results for the First Quarter Ended March 31, 2021 GlobeNewswire
Apr-19-21 04:53AM	Did You Miss ImmuCell's (NASDAQ:ICCC) Impressive 117% Share Price Gain? Simply Wall St. -5.66%
Apr-14-21 05:15PM	ImmuCell Closes $4,250,000 Equity Financing GlobeNewswire
Apr-07-21 08:00AM	ImmuCell Announces Preliminary, Unaudited Sales Results for First Quarter of 2021 GlobeNewswire
Feb-23-21 07:15AM	ImmuCell Corp. to Host Earnings Call ACCESSWIRE -12.01%
Feb-22-21 04:03PM	ImmuCell Makes Important Regulatory Submission and Announces Unaudited Financial Results for the Year Ended December 31, 2020 GlobeNewswire
Feb-16-21 01:42PM	ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2020 GlobeNewswire
Jan-07-21 08:00AM	ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2020 GlobeNewswire
Dec-15-20 04:05PM	ImmuCell Announces Restructuring of its Bank Debt GlobeNewswire
Nov-12-20 04:05PM	ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2020 GlobeNewswire
07:44AM	The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal Benzinga
Nov-05-20 02:10PM	ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2020 GlobeNewswire
Oct-19-20 12:35PM	How Much Does ImmuCell's (NASDAQ:ICCC) CEO Make? Simply Wall St.
Oct-06-20 08:00AM	ImmuCell Announces Preliminary, Unaudited Sales Results for the Quarter Ended September 30, 2020 GlobeNewswire
Aug-12-20 04:05PM	ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2020 GlobeNewswire
Aug-06-20 08:00AM	ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020 GlobeNewswire
Jul-07-20 08:00AM	ImmuCell Announces Preliminary, Unaudited Sales Results for the Second Quarter Ended June 30, 2020 GlobeNewswire
Jun-16-20 08:00AM	ImmuCell Receives $500,000 Loan from the Maine Technology GlobeNewswire
May-18-20 11:48AM	Edited Transcript of ICCC earnings conference call or presentation 14-May-20 1:00pm GMT Thomson Reuters StreetEvents
May-14-20 01:35PM	ImmuCell Corporation to Present at Lytham Partners Virtual Investor Conference PR Newswire
08:42AM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders GlobeNewswire
May-13-20 04:05PM	ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2020 GlobeNewswire
May-07-20 12:00PM	ImmuCell to Announce Unaudited Financial Results for First Quarter of 2020 GlobeNewswire -6.87%
Apr-20-20 10:52AM	Does ImmuCell Corporation (NASDAQ:ICCC) Have A High Beta? Simply Wall St.
Apr-14-20 08:00AM	ImmuCell Receives $938,000 in Support under the Paycheck Protection Program GlobeNewswire
Apr-03-20 07:36AM	The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO Benzinga
Apr-02-20 04:29PM	ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020 GlobeNewswire -8.99%
Mar-11-20 04:05PM	ImmuCell Announces Refinancing of its Bank Debt GlobeNewswire
Mar-01-20 09:09AM	Why ImmuCell Corporation's (NASDAQ:ICCC) CEO Pay Matters To You Simply Wall St.
Feb-26-20 01:09AM	Edited Transcript of ICCC earnings conference call or presentation 19-Feb-20 2:00pm GMT Thomson Reuters StreetEvents
Feb-19-20 12:35PM	ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($0.06) to ($0.04) for the Quarter Ended December 31, 2019 GlobeNewswire
Feb-18-20 04:05PM	ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2019 GlobeNewswire +5.51%
Feb-13-20 09:17AM	ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019 GlobeNewswire
Jan-24-20 12:04PM	Why I Love Trading A Small Account, And Why You Should Too Benzinga
08:35AM	Imagine Owning ImmuCell (NASDAQ:ICCC) And Wondering If The 32% Share Price Slide Is Justified Simply Wall St.
Jan-21-20 12:30PM	ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019 GlobeNewswire +19.28%
Jan-06-20 02:25PM	Edited Transcript of ICCC earnings conference call or presentation 11-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Dec-22-19 01:21PM	Hedge Funds Have Never Been More Bullish On ImmuCell Corporation (ICCC) Insider Monkey
Dec-19-19 11:38AM	Is ImmuCell (NASDAQ:ICCC) Weighed On By Its Debt Load? Simply Wall St.
Nov-12-19 09:37AM	Does ImmuCell Corporation (NASDAQ:ICCC) Have A Volatile Share Price? Simply Wall St.
Nov-11-19 04:05PM	ImmuCell Announces Unaudited Financial Results for Third Quarter of 2019 GlobeNewswire
Nov-05-19 08:00AM	ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2019 GlobeNewswire
Sep-17-19 08:00AM	ImmuCell Enters into Lease Agreement for a Facility to Expand First Defense® Production Capacity GlobeNewswire
Sep-11-19 08:00AM	ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain GlobeNewswire
Sep-06-19 11:43PM	Edited Transcript of ICCC earnings conference call or presentation 13-Aug-19 1:00pm GMT Thomson Reuters StreetEvents -6.02%
Aug-29-19 08:00AM	ImmuCell Receives FDA Response To First CMC Submission for Re-Tain GlobeNewswire
Aug-12-19 04:05PM	ImmuCell Announces Unaudited Financial Results for Second Quarter of 2019 GlobeNewswire
Aug-11-19 03:46PM	The Week Ahead In Biotech: Vanda Awaits FDA Decision, BioVie Plans IPO Benzinga
Aug-06-19 08:00AM	ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019 GlobeNewswire
May-21-19 11:20AM	Edited Transcript of ICCC earnings conference call or presentation 14-May-19 1:00pm GMT Thomson Reuters StreetEvents
May-14-19 07:42AM	The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings Benzinga
May-13-19 04:05PM	ImmuCell Announces Unaudited Financial Results for First Quarter of 2019 GlobeNewswire
May-07-19 09:00AM	ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019 GlobeNewswire +5.79%
Mar-29-19 11:45AM	ImmuCell Corporation Announces Closing of $9 Million Public Offering of Common Stock GlobeNewswire
Mar-27-19 07:30AM	ImmuCell Corporation Announces Pricing of $9.0 Million Public Offering of Common Stock GlobeNewswire -11.44%
Mar-26-19 04:10PM	ImmuCell Corporation Announces Commencement of Public Offering of Common Stock GlobeNewswire
Mar-22-19 10:48AM	ImmuCell Corp (ICCC) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Mar-07-19 02:04PM	Do Directors Own ImmuCell Corporation (NASDAQ:ICCC) Shares? Simply Wall St.
Feb-28-19 02:00PM	ImmuCell Announces Submission of Manufacturing Technical Section for its Purified Nisin Product GlobeNewswire
Feb-14-19 07:50AM	The Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage Trial Benzinga -6.93%
Feb-13-19 04:05PM	ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2018 GlobeNewswire
Feb-06-19 09:27AM	ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2018 GlobeNewswire
Jan-11-19 02:00PM	Edited Transcript of ICCC earnings conference call or presentation 14-Nov-18 2:00pm GMT Thomson Reuters StreetEvents
Dec-11-18 08:00AM	ImmuCell Announces USDA Approval of Dual-Force First Defense® GlobeNewswire
Nov-23-18 08:00AM	Report: Developing Opportunities within ReWalk Robotics, ImmuCell, SCYNEXIS, Fuel Tech, Garrison Capital, and AMREP Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-13-18 04:05PM	ImmuCell Announces Financial Results for Third Quarter of 2018 GlobeNewswire
Nov-08-18 08:00AM	ImmuCell to Participate at 9th Annual Craig-Hallum Alpha Select Conference GlobeNewswire
Nov-07-18 09:16AM	ImmuCell to Announce Financial Results for Third Quarter of 2018 GlobeNewswire
Sep-26-18 03:25PM	Could ImmuCell Corporations (NASDAQ:ICCC) Investor Composition Impacts Your Returns? Simply Wall St.
Sep-25-18 04:16PM	ImmuCell Announces Issuance of Human Food Safety Technical Section Complete Letter for its Purified Nisin Product GlobeNewswire
Aug-30-18 11:02AM	Edited Transcript of ICCC earnings conference call or presentation 14-Aug-18 1:00pm GMT Thomson Reuters StreetEvents
Aug-14-18 07:00AM	ImmuCell Corporation to Host Earnings Call ACCESSWIRE
Aug-13-18 04:05PM	ImmuCell Announces Financial Results for Second Quarter of 2018 GlobeNewswire
Aug-07-18 10:30AM	ImmuCell to Announce Financial Results for Second Quarter of 2018 GlobeNewswire
06:30AM	ImmuCell Hires Senior Director of Quality GlobeNewswire
Jul-25-18 06:30AM	ImmuCell Announces Sale of Certain Non-Core Assets GlobeNewswire
Jul-10-18 06:30AM	ImmuCell Announces Preliminary Sales Results for Second Quarter of 2018 GlobeNewswire +7.18%
Jun-25-18 06:30AM	ImmuCell to Join Russell Microcap Index GlobeNewswire
Jun-07-18 02:02PM	Should You Have ImmuCell Corporations (NASDAQ:ICCC) In Your Portfolio? Simply Wall St.
May-23-18 12:03PM	Edited Transcript of ICCC earnings conference call or presentation 14-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-22-18 07:20AM	Wired News - Stemline Therapeutics' SL-401 BPDCN Program Selected for Clinical Presentations at Upcoming EHA Congress ACCESSWIRE
May-14-18 04:05PM	ImmuCell Announces Financial Results for First Quarter of 2018 GlobeNewswire
12:30PM	ImmuCell Corporation to Host Earnings Call ACCESSWIRE
May-07-18 11:00AM	ImmuCell to Announce Financial Results for First Quarter of 2018 GlobeNewswire
Apr-11-18 02:07PM	Who Are The Largest Shareholders In ImmuCell Corporation (NASDAQ:ICCC)? Simply Wall St.
Mar-05-18 07:55PM	Where ImmuCell Corporation (NASDAQ:ICCC) Stands In Terms Of Earnings Growth Against Its Industry Simply Wall St.
Feb-12-18 07:16AM	Edited Transcript of ICCC earnings conference call or presentation 8-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
Feb-08-18 04:05PM	ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017 GlobeNewswire
12:00PM	ImmuCell Corporation to Host Earnings Call ACCESSWIRE
Feb-05-18 05:10PM	ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2017 GlobeNewswire
Jan-30-18 06:30AM	ImmuCell Appoints Two New Members to its Board of Directors GlobeNewswire
Dec-25-17 09:31AM	ImmuCell Corp. :ICCC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017 Capital Cube
Dec-21-17 11:00AM	ImmuCell Corporation Announces Closing of $3 Million Public Offering of Common Stock GlobeNewswire
Dec-19-17 06:30AM	ImmuCell Corporation Announces Pricing of $3 Million Public Offering of Common Shares GlobeNewswire
Nov-22-17 02:48PM	Edited Transcript of ICCC earnings conference call or presentation 13-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-13-17 04:05PM	ImmuCell Announces Financial Results for Third Quarter of 2017 GlobeNewswire
11:30AM	ImmuCell Achieves USDA Approval of New Product Claim to Prevent Rotavirus Infections GlobeNewswire
Nov-07-17 06:30AM	ImmuCell Announces Completion of Construction of Nisin Production Facility GlobeNewswire

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. The company sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience